KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Amortization - IntangiblesConsolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome from Non-Controlling InterestsIncome towards Parent CompanyInterest ExpensesNet Income towards Common StockholdersOperating ExpensesOperating IncomeOther Operating ExpensesProfit After TaxRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Elevance Health (ELV) Gross Profit (2016 - 2025)

Elevance Health (ELV) has disclosed Gross Profit for 17 consecutive years, with $44.5 billion as the latest value for Q2 2025.

  • On a quarterly basis, Gross Profit changed N/A to $44.5 billion in Q2 2025 year-over-year; TTM through Jun 2025 was $105.7 billion, a N/A change, with the full-year FY2024 number at $157.3 billion, up 2.09% from a year prior.
  • Gross Profit was $44.5 billion for Q2 2025 at Elevance Health, up from $43.9 billion in the prior quarter.
  • In the past five years, Gross Profit ranged from a high of $44.5 billion in Q2 2025 to a low of -$8.8 billion in Q4 2021.
  • A 5-year average of $18.4 billion and a median of $10.5 billion in 2022 define the central range for Gross Profit.
  • Peak YoY movement for Gross Profit: plummeted 129.86% in 2021, then soared 752.58% in 2025.
  • Elevance Health's Gross Profit stood at -$8.8 billion in 2021, then surged by 199.97% to $8.7 billion in 2022, then soared by 342.94% to $38.7 billion in 2023, then plummeted by 68.63% to $12.2 billion in 2024, then soared by 265.9% to $44.5 billion in 2025.
  • Per Business Quant, the three most recent readings for ELV's Gross Profit are $44.5 billion (Q2 2025), $43.9 billion (Q1 2025), and $12.2 billion (Q3 2024).